Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong

Outbreak investigation of airborne transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a restaurant: implication for enhancement of indoor air dilution

(2022) Vincent Chi-Chung Cheng et al.   JOURNAL OF HAZARDOUS MATERIALS

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

(2022) Eddy Pérez-Then et al.   NATURE MEDICINE

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

(2022) Peter B. Gilbert et al.   SCIENCE

Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults

(2022) Addi J. Romero-Olmedo et al.   Nature Microbiology

Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study

(2022) Burc Barin et al.   Lancet Microbe

A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19

(2022) David Tak Wai Lui et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

(2022) Sho Iketani et al.   NATURE

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

(2022) Jingyou Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Understanding the societal factors of vaccine acceptance and hesitancy: evidence from Hong Kong

(2022) Bobo Hi Po Lau et al.   PUBLIC HEALTH

The immunology and immunopathology of COVID-19

(2022) Miriam Merad et al.   SCIENCE

COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022

(2022) Dallas J. Smith et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines

(2022) Ruiqi Zhang et al.   mSphere

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines

(2022) Lu Lu et al.   EBioMedicine

Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test

(2022) Michele Mun Hei Chan et al.   Microbiology Spectrum

Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2

(2022) Lin-Lei Chen et al.   Lancet Microbe

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

(2021) Jennifer M. Dan et al.   SCIENCE

Lessons learned one year after SARS-CoV-2 emergence leading to COVID-19 pandemic

(2021) Kelvin Kai-Wang To et al.   Emerging Microbes & Infections

Multipronged infection control strategy to achieve zero nosocomial coronavirus disease 2019 (COVID-19) cases among Hong Kong healthcare workers in the first 300 days of the pandemic

(2021) Vincent Chi-Chung Cheng et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Considerations in boosting COVID-19 vaccine immune responses

(2021) Philip R Krause et al.   LANCET

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

(2021) Matthias Tenbusch et al.   LANCET INFECTIOUS DISEASES

Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study

(2021) Denis Sauré et al.   LANCET INFECTIOUS DISEASES

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

(2021) Nassim Kamar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

(2021) Stephen J. Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

(2021) Jia Wei et al.   Nature Microbiology

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

(2021) Michael J. Peluso et al.   Science Advances

High compliance to infection control measures prevented guest-to-staff transmission in COVID-19 quarantine hotels

(2021) Xin Li et al.   JOURNAL OF INFECTION

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

(2021) Mark A Brockman et al.   JOURNAL OF INFECTIOUS DISEASES

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

(2021) Shuo Feng et al.   NATURE MEDICINE

Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China

(2021) Jiahao Wang et al.   Human Vaccines & Immunotherapeutics

Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents

(2021) Hing Wai Tsang et al.   Frontiers in Immunology

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant

(2021) Ruiqi Zhang et al.   Vaccines

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples

(2021) Kwok-Hung Chan et al.   Diagnostics

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

(2020) Jasper Fuk-Woo Chan et al.   LANCET

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

(2020) Kelvin Kai-Wang To et al.   LANCET INFECTIOUS DISEASES

Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong

(2020) Kelvin Kai-Wang To et al.   CLINICAL INFECTIOUS DISEASES

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

(2020) Sheila F. Lumley et al.   NEW ENGLAND JOURNAL OF MEDICINE